ReachMD

Dr. David M. Kendall serves as chief scientific and medical officer for the American Diabetes Association (ADA) in Alexandria, Virginia. In this role he provides leadership and oversight of the Association's scientific and medical activities including medical affairs, research programs, medical and community information, scientific and consumer publications and professional education. 

In addition to his role with ADA, Dr. Kendall holds an academic appointment as associate professor of medicine at the University of Minnesota and serves as an adjunct medical director at the International Diabetes Center both in Minneapolis.

With more than a decade of service to the International Diabetes Center, Dr. Kendall previously served as medical director and chief of clinical and professional services from 2008-2009 and chief of clinical services from 1997-2005. He was previously the executive director of medical affairs at Amylin Pharmaceuticals from 2005-2008 and served as full-time faculty at the University of Minnesota Medical School from 1994-1997.

Active in a broad array of diabetes research activities, medical education and clinical care for nearly 25 years, Dr. Kendall's research and clinical interests have emphasized the management of both type 1 and type 2 diabetes, emerging and novel therapies for diabetes care, the treatment and prevention of complications of diabetes and studies of models of diabetes care delivery.

He has authored more than 170 original manuscripts, chapters and professional reviews. Additionally, Dr. Kendall has served as an investigator in both the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications (DCCT/EDIC) Trial and as a principle investigator for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial in type 2 diabetes.